Literature DB >> 1685880

Taurine, a possible urinary marker of liver damage: a study of taurine excretion in carbon tetrachloride-treated rats.

C J Waterfield1, J A Turton, M D Scales, J A Timbrell.   

Abstract

Carbon tetrachloride (CCl4) caused a dose-dependent increase in urinary taurine which correlated with both the histological and biochemical assessment of liver damage. The peak elevation in urinary taurine occurred within the first 48 h after dosing but there was still significant taurinuria 72 and 96 h after the intermediate dose (1 ml.kg-1) and highest dose (2 ml.kg-1), respectively. Levels of taurine in serum were also elevated over the 24 h period following a hepatotoxic dose (2 ml.kg-1) of CCl4. In contrast, although initially elevated, levels of taurine in the liver declined over the 24 h period following dosing and were significantly lower 96 h after a hepatotoxic dose of CCl4 (2 ml.kg-1). Male rats showed a different urinary profile for taurine than female rats after dosing with CCl4. A reduction in food intake seemed to lower urinary taurine levels although these changes were not statistically significant. There was a significant correlation between the level of urinary taurine and the level of serum AST for individual animals given a hepatotoxic dose of CCl4 (2 ml.kg-1). The data presented suggest that: i) taurine is produced by the liver in response to a toxic insult and subsequent leakage from damaged cells leads to increased levels in the urine; ii) the urinary taurine level may be a useful non-invasive marker of liver damage.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1685880     DOI: 10.1007/bf01973715

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  24 in total

1.  Drug-induced muscle necrosis with massive taurinuria.

Authors:  D H BOWDEN; R A GOYER
Journal:  Arch Pathol       Date:  1962-08

2.  A new method for the determination of taurine in tissues.

Authors:  J E GARVIN
Journal:  Arch Biochem Biophys       Date:  1960-12       Impact factor: 4.013

3.  Increased urinary excretion of taurine and urea by rats after x-irradiation.

Authors:  R E KAY; J C EARLY; C ENTENMAN
Journal:  Radiat Res       Date:  1957-01       Impact factor: 2.841

4.  Taurine synthesis in isolated rat hepatocytes in suspension exposed to carbon tetrachloride.

Authors:  C J Waterfield; J A Turton; M D Scales; J A Timbrell
Journal:  Biochem Soc Trans       Date:  1990-12       Impact factor: 5.407

5.  Investigations into the biochemical effects of region-specific nephrotoxins.

Authors:  K P Gartland; F W Bonner; J K Nicholson
Journal:  Mol Pharmacol       Date:  1989-02       Impact factor: 4.436

6.  Taurine and isethionic acid: distribution and interconversion in the rat.

Authors:  R Huxtable; R Bressler
Journal:  J Nutr       Date:  1972-07       Impact factor: 4.798

7.  A routine procedure for estimating serum gamma-glutamyltranspeptidase activity.

Authors:  L Naftalin; M Sexton; J F Whitaker; D Tracey
Journal:  Clin Chim Acta       Date:  1969-11       Impact factor: 3.786

8.  Fluorometric estimation of taurine in tissue extracts and biological fluids.

Authors:  S C Datta; A Naryanaswami
Journal:  Ital J Biochem       Date:  1983 Sep-Oct

9.  Simplified two-step column-chromatographic determination of taurine in urine.

Authors:  M A Anzano; J O Naewbanij; A J Lamb
Journal:  Clin Chem       Date:  1978-02       Impact factor: 8.327

10.  A comparison by species, age and sex of cysteinesulfinate decarboxylase activity and taurine concentration in liver and brain of animals.

Authors:  J A Worden; M H Stipanuk
Journal:  Comp Biochem Physiol B       Date:  1985
View more
  18 in total

1.  Radiation metabolomics. 1. Identification of minimally invasive urine biomarkers for gamma-radiation exposure in mice.

Authors:  John B Tyburski; Andrew D Patterson; Kristopher W Krausz; Josef Slavík; Albert J Fornace; Frank J Gonzalez; Jeffrey R Idle
Journal:  Radiat Res       Date:  2008-07       Impact factor: 2.841

2.  Neuroactive amino acids in hepatic encephalopathy.

Authors:  R F Butterworth
Journal:  Metab Brain Dis       Date:  1996-06       Impact factor: 3.584

3.  Proton NMR spectroscopic studies on the metabolism and biochemical effects of hydrazine in vivo.

Authors:  S M Sanins; J A Timbrell; C Elcombe; J K Nicholson
Journal:  Arch Toxicol       Date:  1992       Impact factor: 5.153

4.  Electrically-evoked release of taurine in the rat vas deferens: evidence for a purinoceptor-mediated effect.

Authors:  G Queiroz; J Gonçalves; F Carvalho; P Vale
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-01       Impact factor: 3.000

5.  Studies on the muscle toxicant 2,3,5,6-tetramethyl p-phenylenediamine: effects on various biomarkers including urinary creatine and taurine.

Authors:  R P Draper; C J Waterfield; M J York; J A Timbrell
Journal:  Arch Toxicol       Date:  1994       Impact factor: 5.153

6.  Effect of various non-hepatotoxic compounds on urinary and liver taurine levels in rats.

Authors:  C J Waterfield; J A Turton; M D Scales; J A Timbrell
Journal:  Arch Toxicol       Date:  1993       Impact factor: 5.153

7.  Investigations into the effects of various hepatotoxic compounds on urinary and liver taurine levels in rats.

Authors:  C J Waterfield; J A Turton; M D Scales; J A Timbrell
Journal:  Arch Toxicol       Date:  1993       Impact factor: 5.153

8.  Dysautonomia in autism spectrum disorder: case reports of a family with review of the literature.

Authors:  Derrick Lonsdale; Raymond J Shamberger; Mark E Obrenovich
Journal:  Autism Res Treat       Date:  2011-05-31

9.  Pharmacokinetics of oral taurine in healthy volunteers.

Authors:  Mohammadreza Ghandforoush-Sattari; Siminozar Mashayekhi; Channarayapatna V Krishna; John P Thompson; Philipp A Routledge
Journal:  J Amino Acids       Date:  2010-06-29

10.  Taurine reduces the secretion of apolipoprotein B100 and lipids in HepG2 cells.

Authors:  Teruyoshi Yanagita; Seo-Young Han; Ying Hu; Koji Nagao; Hideaki Kitajima; Shigeru Murakami
Journal:  Lipids Health Dis       Date:  2008-10-17       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.